Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
City of Hope Medical Center
City of Hope Medical Center
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
Stanford University
Thomas Jefferson University
University College, London
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Therapeutic Advances in Childhood Leukemia Consortium
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Gruppo Italiano Malattie EMatologiche dell'Adulto
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University Hospital Schleswig-Holstein
Therapeutic Advances in Childhood Leukemia Consortium
Stanford University
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
Abramson Cancer Center at Penn Medicine
Gruppo Italiano Malattie EMatologiche dell'Adulto
Wake Forest University Health Sciences
St. Jude Children's Research Hospital
Barbara Ann Karmanos Cancer Institute
Massachusetts General Hospital
Children's Oncology Group
Stanford University
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
SWOG Cancer Research Network
Associazione Italiana Ematologia Oncologia Pediatrica
Dana-Farber Cancer Institute
Swedish Orphan Biovitrum
City of Hope Medical Center
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
St. Jude Children's Research Hospital
Sanofi